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ABSTRACT
Controlling recurrent infectious diseases is a vital yet complicated
problem in global health. During the long period of time from pa-
tients becoming infected to finally seeking treatment, their close
contacts are exposed and vulnerable to the disease they carry. Ac-
tive screening (or case finding) methods seek to actively discover
undiagnosed cases by screening contacts of known infected peo-
ple to reduce the spread of the disease. Existing practice of active
screening methods often screen all contacts of an infected person,
requiring a large budget. In cooperation with a research institute
in India, we develop a model of the active screening problem and
present a software agent, REMEDY. This agent assists maximizing
effectiveness of active screening under real world budgetary con-
straints and limited contact information. Our contributions are: (1)
A new approach to modeling multi-round network-based screen-
ing/contact tracing under uncertainty and proof of its NP-hardness;
(2) Two novel algorithms, Full- and Fast-REMEDY. Full-REMEDY
considers the effect of future actions and provides high solution
quality, whereas Fast-REMEDY scales linearly in the size of the
network; (3) Evaluation of Full- and Fast-REMEDY on several
real-world datasets which emulate human contact to show that
they control diseases better than the baselines. We also show that
the software agent is robust to errors in estimates of disease pa-
rameters, and incomplete information of the contact network. Our
software agent is currently under review before deployment as a
means to improve the efficiency of district-wise active screening
for tuberculosis in India.
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1 INTRODUCTION
Contagious diseases, such as tuberculosis, influenza and sexually
transmitted diseases (STDs) (e.g., gonorrhea and chlamydia) are
critical public-health challenges that continue to threaten lives and
impose significant economic burden on society. For example, the
economic loss due to influenza in the USA alone is estimated to
be $11.2 billion in 2015 [30]. While low-cost treatment programs
are available, individuals ignore symptoms and delay care, increas-
ing transmission risk. As a result, health agencies engage in active
screening or contact tracing efforts as figure 1 shows, where individ-
uals are asked to undergo diagnostic tests and offered treatment if
tests are positive [7, 14]. However, active screening is expensive in
developing countries. Even in the USA, Braxton et al. [6] state that
“In 2012, 52% of state and local STD programs experienced budget
cuts. This amounts to reductions in clinic hours, contact tracing,
and screening for common STDs.” In India, an estimated 1 million
missing tuberculosis (TB) cases require an efficient method of active
screening, particularly given limited health budgets [10]. Efficiently
identifying and intervening for infectious cases is therefore of vital
importance.
(a) Passive screening (b) Active screening
Figure 1: Passive screening only treats patients who come
to clinic voluntarily whereas active screening can treat pa-
tients in hard-to-reach tribal areas at a higher cost [40]
There is a huge body of literature on spread and control of recur-
rent diseases (no permanent immunity) [3, 16, 37, 42, 47]. However,
these prior studies assume perfect observation of who is infected
and who is not. Also, most of these methods focus on eradication of
disease, which is not possible if the screening resources are limited.
Thus, important real world characteristics such as partial observa-
tion and limited resources have not been adequately handled in
prior work.
To address this shortcoming in active screening of recurrent
diseases, we develop a model of the active screening problem and
present an adaptive software agent, REMEDY (REcurrent screening
Multi-round Efficient DYnamic agent). We develop our model in
cooperation with a research institute in India (name withheld for
anonymity of authors), which partners with the Central Tubercu-
losis Division (CTD) of India to facilitate active screening for TB.
REMEDY assists maximizing effectiveness of active screening under
real world budgetary constraints and limited contact information.
Such screening of TB patients currently takes place quarterly in
over 50 districts scattered across 18 states of India. REMEDY is
intended to assist health workers in India in their work in active
screening in the field. Our software agent is currently under review
before deployment as a means to improve the efficiency of district-
wise active screening for tuberculosis in India, although REMEDY
has applicability for active screening of other recurrent diseases.
REMEDY is based on three main contributions. Our first con-
tribution is a model of the multiagent active screening problem
(ACTS). We focus on spread of recurrent infectious diseases mod-
eled using the well-known network SIS model in computational
epidemiology [43], which is applicable for many diseases such as
syphilis and typhoid. It is the foundation of more complex models
that capture more disease dynamics (such as latent states, variation
in birth/death rates, or multiple treatment states). The network SIS
model is specified by a graph where nodes are individuals and edges
indicate physical contact through which disease spread is proba-
bilistic. ACTS models multi-agent interactions in that the nodes in
the graph model individuals who interact with other individuals.
The individuals can be either susceptible (S) or infected (I). The
contribution of multiagent systems in computational epidemiology
is well recognized in previous literature [38]. Our model further
includes real-world constraints, namely that health workers are un-
certain about the health state of individuals, have a small screening
budget relative to the population size, and must engage in active
screening over multiple rounds (time periods) due to recurrent of
the disease. As a first result, we prove that the ACTS problem is
NP-hard. To the best of our knowledge, no other model in the AI lit-
erature has considered multi-round active screening with partially
observable health state for controlling disease spread.
Our second contribution is two novel algorithms, Full- and Fast-
REMEDY. In the former, we consider the effect of both current and
future screening actions to solve the ACTS problem. Full-REMEDY
achieves scale-up via an innovative combination of : (i) easier to
optimize upper-bound of the ACTS objective; (ii) a Frank-Wolfe
Style gradient descent algorithm; (iii) compact representation of
belief states to represent uncertainty. Fast-REMEDY works in a
similar fashion as Full-REMEDY, but by optimizing just the cur-
rent step actions runs almost two orders of magnitude faster than
Full-REMEDY in practice. As our third contribution, we illustrate
the benefits of Full- and Fast-REMEDY via extensive testing on
seven different real-world human contact networks against var-
ious baselines across a range of realistic disease parameters. For
the largest network of ∼76,000 individuals we see improvements
in performance of almost 40% over the prior best method which
directly maps to thousands of fewer infections every six months.
REMEDY is developed to assist screening for infectious diseases
under conditions where screening tests are expensive, budgets are
limited, and information on the underlying social graph is avail-
able. As we also show, the performance improvements exhibited by
Full- and Fast-REMEDY are robust to varying levels of missing
information in the social graph and budget change, thus enabling
the use of our agent to improve the current practice of real-world
screening contexts.
2 RELATEDWORK
Epidemic models continue to be widely used across biological, so-
cial, and computer sciences. Applications range widely, including
influence propagation [22], rumor adoption [44], computer virus
suppression [17], and of course, disease spread. The studies of
disease spreading history can date back to as early as 1760 when
Bernoulli proposed the first mathematical epidemic model for small-
pox (Variola Major) [5]. In early 2000, studies [43] have found that
graph-based epidemic propagation models provide a more realis-
tic approach compared to fully mixed models of earlier literature.
Under these graph-based models, non-recurrent and recurrent dis-
ease suppression and eradication have been studied using different
approaches.
Non-Recurrent Diseases: A large portion of work related to ac-
tive screening deals primarily with SIR or SEIR type diseases (with
two extra state Exposed and Recovered), often referred to as the
Vaccination Problem [3, 16, 37, 42, 47], where permanent immuniza-
tion (entry into 𝑅 state) can be viewed as removing nodes from the
graph. Exploiting this idea, Saha et al. [34] and Tong et al. [39] fo-
cus on immunization ahead of an epidemic and suggest a heuristic
method of removing a set of 𝑘 nodes based on the eigenvalues of
the adjacency matrix. Zhang and Prakash [47] consider the problem
of selecting the best 𝑘 nodes to immunize in a network after the
disease has started to spread. Ren et al. [31] extend the problem to
tackle network with graph structure uncertainty. These methods
do not apply to our scenario as they assume that a single round of
screening offers permanent immunity.
Recurrent Diseases: For diseases in which there is no permanent
immunity, one-time screening (cure) is not enough and, further, it
may not be reasonable to quarantine patients until the disease has
died out. When the true state of the graph in every round is known
(in other words, when the policymaker has perfect observations),
given certain budget constraints, Drakopoulos et al. [12, 13] provide
a theoretical lower bound on the expected time needed to eradicate
the disease, which grows linearly in the number of nodes. The
authors provide a policy to show that disease eradication is possible
when the graph structure and budget have specific properties under
such perfect observation. Scaman et al. [36] provide a scalable
algorithm maxcut minimization and tighter theoretical bound of
the eradication time based on the idea.
Our work differs from studies of recurrent diseases that assume
perfect observations and seek to bound eradication time [12, 13,
36]. The impact of curing uncertainty in these previous works
is analyzed in Hoffman and Caramanis [19] by providing non-
constructive, algorithm-independent bounds, motivating our work.
We focus on developing algorithms to minimize the disease spread.
To the best of our knowledge, this complex setting has not been
studied previously. Although both inherently a multiagent problem
because nodes (agents) make decisions in response to those around
them, this problem of minimizing disease spread is different from
another well-studied multiagent problem of influence maximization
in general [9, 22, 26, 45, 46]. The influence maximization problem
optimizes the selection of seeds or starting nodes for maximizing in-
fluence spread that usually has sub-modular property to exploit, as
opposed to optimizing the selection of nodes on which to intervene
to minimize disease spread.
3 DISEASE MODEL
We introduce the disease model for our problem, which is based on
the well-known SIS model [1, 2]. An individual can either be in state
𝑆 (a healthy individual susceptible to disease) or 𝐼 (the individual is
infected). SIS models capture the dynamics of recurrent diseases,
where permanent immunity is not possible (e.g., TB, typhoid).
We adopt a discrete time SIS model for modeling the disease dy-
namics propagating on a graph. We summarize our notation in the
supplement material. 1 Given a contact network 𝐺 (𝑉 , 𝐸), infection
spreads via the edges in the network. There are |𝑉 | individuals, and
we use 𝛿 (𝑣) to denote neighbors of node 𝑣 in the network. Each indi-
vidual (node) 𝑣 in the network at time t is in state s𝑣 (𝑡) ∈ {𝑆, 𝐼 }. Let
t𝑣 (𝑡) denote the state vector that represents the true state of node
𝑣 at time 𝑡 where 𝑆 is represented as [1, 0]⊤ and 𝐼 as [0, 1]⊤. Given
the initial state, an infected node infects its healthy neighbors with
rate 𝛼 independently and recovers with probability 𝑐 . The latter
term represents the probability that the node may visit a doctor on
its own initiative. The health state transition probabilities of a node
is then given by 𝑃 [𝑠𝑣 (𝑡 + 1) = {𝑆, 𝐼 }] = T𝑁𝑣 (𝑡)t𝑣 (𝑡) where
T𝑁𝑣 (𝑡 ) =
𝑆 𝐼[ ]
𝑆 1 − 𝑞𝑣 𝑐
𝐼 𝑞𝑣 1 − 𝑐 , (1)
and 𝑞𝑣 = 1 − (1 − 𝛼) | {𝑢∈𝛿 (𝑣) | su (𝑡 )=𝐼 } | . The columns denote the
state of 𝑣 at time 𝑡 and the rows denote the state at 𝑡 + 1. The tran-
sition probabilities follow the disease dynamics described earlier.
In particular, 𝑞𝑣 captures the exact probability that node 𝑣 becomes
infected from its neighbors {𝑢 ∈ 𝛿 (𝑣) | su (𝑡) = 𝐼 } and 𝑐 captures
the probability that 𝐼 individuals seek treatment voluntarily.
Given such transition probabilities and an initial state, if no
intervention happens, the network state evolves by flipping biased
coins for each node to determine their next true state in each round.
The process is repeated until the terminal step 𝑇 is reached.
4 THE ACTIVE SCREENING (ACTS) PROBLEM
Motivated by active screening/contact tracing campaigns that have
been practiced since the 1980s [7] and applied in various forms/dis-
eases [6], we propose the Active Screening (ACTS) Problem. Given
the SIS model in the previous section, an active screening agent
seeks to determine the best node sets 𝐶𝑎 (𝑡) ⊂ 𝑉 to actively screen
and cure with a limited budget of |𝐶𝑎 (𝑡) | ≤ 𝑘 at each round 𝑡 . The
agent does not know the ground truth health state of all individu-
als. The agent knows the network structure 𝐺 (𝑉 , 𝐸), the infection
probability 𝛼 , and recovery probability 𝑐 . In addition, the agent
observes the naturally cured node set 𝐶𝑛 (𝑡) at time 𝑡—because this
set of patients come to the clinic voluntarily. Active screening starts
after the agent acquires information about 𝐶𝑛 (𝑡). Let 𝐶𝑎 (𝑡) be the
set of nodes that are actively screened at time 𝑡 . A node 𝑣 ∈ 𝐶𝑎 (𝑡)
1Appendix Link: https://bit.ly/2H0uCyK
becomes cured at time 𝑡 + 1. Thus, the transition matrix for a node
𝑣 ∈ 𝐶𝑎 (𝑡) is 𝑃 [𝑠𝑣 (𝑡 + 1) = {𝑆, 𝐼 }] = T𝐴𝑣 (𝑡)tv (𝑡), where
T𝐴𝑣 (𝑡 ) =
𝑆 𝐼[ ]
𝑆 1 1
𝐼 0 0
. (2)
True state
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Figure 2: The procedure of the ACTS problem.
The action the agent takes at time 𝑡 does not affect the transition
matrix T𝑁𝑣 (𝑡) of the nodes not involved in active screening. Fig. 2
illustrates an example of the problem procedure. The upper part
of the figure shows how the true state of the network evolves and
the lower part of the figure shows the information available to the
algorithm. In this example, there are seven nodes A∼G. In each
round, infected nodes (nodes B, D, and G in the example) flip a coin
and report to the clinic with probability 𝑐 . The algorithm acquires
the information of the nodes that eventually report to the clinic
and are about to be cured, which is {G} this round. Based on this
information, the algorithm will choose a set of nodes, say {D},
to actively screen. These two sets of nodes are guaranteed to be
in 𝑆 state in the next round. After that, the state of the network
transitions and the next round starts.
It is worth noting that although both the nodes that voluntarily
report to the clinic and the nodes that are actively screened are
guaranteed to be in 𝑆 state in the next round, their neighbors may
still be infected by them in the current round. In the example, node
E is infected by node D even though node D was actively screened.
This allows us to simplify the state transitions because curing and
spreading infection occur at the same time.
Our objective is to maximize the health quality of each individual
at each round (in contrast to past work, which primarily focuses
on the cost of eradicating the disease entirely). The objective of the
ACTS problem is:
min
𝐶𝑎 (0),...,𝐶𝑎 (𝑇 )
E
[∑𝑇
𝑡=0
∑
𝑣∈𝑉 1s𝑣 (𝑡 )=𝐼
]
. (3)
Problem Statement. (ACTS Problem) Given a contact network
𝐺 (𝑉 , 𝐸), the disease and active screening model, find an active screen-
ing policy such that the expectation of
∑𝑇
𝑡=0
∑
𝑣∈𝑉 1s𝑣 (𝑡 )=𝐼 is mini-
mized.
Even assuming we know the ground truth infected state for each
node, ACTS is NP-hard. All proofs are in the supplemental material.
Theorem 4.1. The ACTS Problem is NP-hard.
We introduce REMEDY, a software agent for assisting to select
nodes to actively screen in the ACTS problem. REMEDY, shown in
Algorithm 1 has two components: (i) a marginal belief state update
that we use for reasoning about the infected status of nodes, and (ii)
an algorithm for selecting which nodes to actively screen based on
the marginal belief state and an upper bound of the ACTS objective.
4.1 Belief State Update
Tracking the exact probability that a node is infected in ACTS re-
quires storing𝑂 (2 |𝑉 |) values, which is computationally intractable
for reasonably sized graphs. Thus, REMEDYmaintains a belief state
based on the marginal probability that each node is infected, re-
quiring only 𝑂 ( |𝑉 |) values for storage. To calculate the marginal
infection probability for the next round, we have to consider all
possible events of a node’s neighbors are infected or not, which ap-
pears to require computing a sum with exponentially many terms.
We prove in Lemma 4.2 that the sum may be written with a lin-
ear number of terms. However, the marginal belief state discards
correlation between nodes and this may lead to underestimating
the number of infected nodes. We address this issue in the next
section by deriving an upper bound for the true ACTS in terms of
the marginal belief state.
Themarginal belief update is lines 1–7 and 9–15 of Alg. 1. At each
round 𝑡 ∈ {0, . . . ,𝑇 − 1}, we acquire perfect information about the
infected state of each 𝐼 node that naturally recovers, i.e., the nodes
that satisfy 𝑠 (𝑡) = 𝐼 and 𝑠 (𝑡 + 1) = 𝑆 . The state of the remaining
nodes is unknown.
Let 𝑥𝑣 (𝑡) ∈ [0, 1] be the probability that node 𝑣 is in state 𝐼 at
time 𝑡 , and let bv (𝑡) = [1 − 𝑥𝑣 (𝑡), 𝑥𝑣 (𝑡)]⊤ be the marginal belief
vector. For each node, we update an intermediate belief state b¯v (𝑡) =
[1 − 𝑥𝑣 (𝑡), 𝑥𝑣 (𝑡)]⊤ in which 𝑥𝑣 (𝑡) = 1 for 𝑣 ∈ 𝐶𝑛 (𝑡) and 𝑥𝑣 (𝑡) =
(1−𝑐)𝑥𝑣 (𝑡 )
(1−𝑥𝑣 (𝑡 ))+(1−𝑐)𝑥𝑣 (𝑡 ) for the remaining nodes 𝑣 ∈ 𝑉 \𝐶𝑛 (𝑡). These
update steps are in lines 1–7 of Algorithm 1. This intermediate
belief state is then exploited by the action choice subroutine to
select 𝐶𝑎 (𝑡), the node set we actively cure (line 8). After that, we
calculate the marginal belief state at the next round: bv (𝑡 + 1) =
B𝑁𝑣 (𝑡)b¯v (𝑡) and bv (𝑡 + 1) = B𝐴𝑣 (𝑡)b¯v (𝑡) for 𝑣 ∈ 𝑉 \ (𝐶𝑛 (𝑡) ∪𝐶𝑎 (𝑡))
and 𝑣 ∈ 𝐶𝑛 (𝑡) ∪𝐶𝑎 (𝑡) respectively where
B𝑁𝑣 (𝑡 ) =
𝑆 𝐼[ ]
𝑆 1 − 𝑝𝑣 0
𝐼 𝑝𝑣 1
,B𝐴𝑣 (𝑡 ) =
𝑆 𝐼[ ]
𝑆 1 1
𝐼 0 0
(4)
and 𝑝𝑣 = 1 −∏𝑢∈𝛿 (𝑣) (1 − 𝛼𝑥𝑢 (𝑡)). These steps are shown in lines
9-15 of Alg. 1. The transition matrix B𝑁 does not contain parameter
𝑐 because each node in the 𝐼 state that did not naturally recover
will remain in 𝐼 state with probability 1. Note that 𝑝𝑣 is not an
approximation but the exact value calculated by listing all possible
events of 𝑣 ’s neighbor being infected or not which we show in
Lemma 4.2.
Lemma 4.2. The exact marginal probabilities of 𝑃 [𝑠 (𝑡 + 1) =
𝐼 |𝑠 (𝑡) = 𝑆] can be calculated by 𝑝𝑣 .
4.2 Action Choice Algorithm
Possible approaches:We now turn our attention to selecting the
set of nodes to actively screen, i.e., line 8 in Alg. 1. First, treating the
Acts problem as a POMDP and applying state of the art reinforce-
ment learning techniques is not feasible for the real world scenario
we are aiming for [27]. This is due to the fact that the computation
time scales poorly with the high dimension action choice, which
is exponential in the budget for our problem. Even when we ap-
proximated the actual feasible action choice by choosing the nodes
greedily one node at a time and estimating the reward function,
Algorithm 1 REMEDY
Input: A, b(𝑡), 𝛼 , 𝑐 , 𝐶𝑛 (𝑡), 𝑡,𝑇 , 𝑘
Output: 𝐶𝑎 (𝑡), b(𝑡 + 1)
1: for 𝑣 ∈ 𝑉 do
2: if 𝑣 ∈ 𝐶𝑛 (𝑡) then
3: b¯v (𝑡) ← [0, 1]⊤
4: else
5: b¯v (𝑡) ← [ (1−𝑥𝑣 (𝑡 )),(1−𝑐)𝑥𝑣 (𝑡 ) ]
⊤
( (1−𝑥𝑣 (𝑡 ))+(1−𝑐)𝑥𝑣 (𝑡 ))
6: end if
7: end for
8: 𝐶𝑎 (𝑡) ← ActionChoice(A, b¯(𝑡), 𝛼, 𝑐,𝐶𝑛 (𝑡), 𝑡,𝑇 , 𝑘)
9: for 𝑣 ∈ 𝑉 do
10: if 𝑣 ∈ 𝑉 \𝐶𝑛 (𝑡) ∪𝐶𝑎 (𝑡) then
11: bv (𝑡 + 1) ← B𝑁𝑣 (𝑡)b¯v (𝑡)
12: else
13: bv (𝑡 + 1) ← B𝐴𝑣 (𝑡)b¯v (𝑡)
14: end if
15: end for
16: return 𝐶𝑎 (𝑡), b(𝑡 + 1)
the resulting approach performed poorly and did not scale up to 20
nodes, which is less than even the smallest graph in our dataset.
One fast yet naive approach to this problem is to select the node
set with maximum marginal belief to be in 𝐼 state. This approach
can be computed in 𝑂 ( |𝑉 |), but it does not take the network struc-
ture and future infection probabilities into account. For example,
suppose we have a tree structure with a known infection state: the
root is the only infected node. The belief-based approach will screen
the root and spend the remainder of the budget on random nodes.
This is suboptimal because the remaining budget could be spent on
the children of the root to prevent the disease from spreading.
Another approach is to choose nodes based on the graph struc-
ture. For example, we can select the nodes that, if deleted (perma-
nently actively screened), would reduce the largest eigenvalue of
the graph the most [29]. This approach guarantees that the infec-
tion is eradicated in the long term if the largest eigenvalue can
be reduced below 𝑐𝛼 for sufficient budget 𝑘 . However, structure
based approaches perform poorly when there are many nodes with
identical roles in the graph structure, e.g., in symmetric graphs.
Here, belief information would be more useful because it takes into
account current signals from local neighbors of nodes
Our approach: The key novelty of our software agent is that it
brings together three key features: the use of belief states, a Frank-
Wolfe style gradient-based algorithm for efficient reasoning about
the structure of the graph, and use of an upper-bound of the true
ACTS objective. Whereas algorithms for active screening have
typically used discrete reasoning such as Markov chain (see Related
work) and have not appealed to gradient-based approaches, it is
the novel combination of this gradient-based approach with the
use of belief states and upper bounds that is key in our work. Note
that whereas marginal belief states avoid the exponential storage
requirement of exact belief states, they typically underestimate the
expected number of infected nodes as a result of the lost correlation
information. We rely on using an upper bound on true number
of infected nodes reduces this effect — thus we face the issue of
determining a suitable upper bound. Our desiderata for determining
this upper bound are therefore: (i) encapsulate the observations
and actions of past and future, (ii) provide a performance guarantee
compensating the information lost from marginal belief state, and
(iii) be minimizable in time polynomial in 𝑇 , 𝑘 and |𝑉 |.
We develop two different algorithms for action choice: Full-
ActionChoice, which looks ahead through all future actions and
Fast-ActionChoice, a less computationally intensive variant that
considers only the current action, allowing it to exploit eigenvalue
decomposition. We refer to REMEDY agent using Full and Fast-
ActionChoice as Full and Fast-REMEDY.
We start with some preliminary notation. To encapsulate the
effect of active-screening toward our objective function, we define
the |𝑉 | × |𝑉 | diagonal action matrix R𝑎 (𝑡) at time 𝑡 as R𝑎 (𝑡)𝑣,𝑣 = 1 if
and only if 𝑣 ∈ 𝐶𝑎 (𝑡), and 0 otherwise. For the current round, say 𝑡0,
we observe the nodes that are cured and need to decide the nodes
to actively screen. We define the naturally cured matrix R𝑛 (𝑡0) as
R𝑛 (𝑡0)𝑣,𝑣 = 1 if and only if 𝑣 ∈ 𝐶𝑛 (𝑡0), which encapsulates the
knowledge we gain from natural recovery in the current round.
Let vector x(𝑡) represent 𝑥𝑣 (𝑡) for all 𝑣 . To bound x(𝑡) across all
rounds given the actions we take, let M′ = 𝛼A + I, where A is
the adjacency matrix and I is the identity matrix, define the upper
bound transition matrix for the current round (𝑡 = 𝑡0) as M𝑎 (𝑡0) =
(I − R𝑎 (𝑡0) − R𝑛 (𝑡0))M′. And for future rounds (𝑡 > 𝑡0), we define
it as M𝑎 (𝑡) = (I − R𝑎 (𝑡))M where M = 𝛼A + (1 − 𝑐)I.
Theorem 4.3. Let the current time be 𝑡0. M𝑎 is defined as above
for 𝑡0 and 𝑡 > 𝑡0. The ACTS objective (Eq. 3) is bounded above by:
E[
𝑇∑
𝑡=𝑡0
∑
𝑣∈𝑉
|𝑠𝑣 (𝑡 ) = 𝐼 | ] ≤ 𝐹 = 1⊤
𝑇∑
𝑡=𝑡0
𝑡∏
𝜏=𝑡0
M𝑎 (𝜏)x(𝑡0) (5)
where
𝑡∏
𝜏=𝑡0
M𝑎 (𝜏) = M𝑎 (𝑡 )M𝑎 (𝑡 − 1) ...M𝑎 (𝑡0) . (6)
Given that the function 𝐹 upper bounds our objective function,
we next describe the method we use to select the action matrix
𝑅𝑎 (𝑡) that minimizes 𝐹 for every round. Distinct from previous
literature, our objective takes into account the number of infected
nodes at each round. We also have the flexibility to change the
action we take based on the observation we make in each round.
Such flexibility results a solution space of size
( |𝑉 |
𝑘
)𝑇
, making the
bound challenging to optimize exactly, since it is nonconvex. Hence,
we apply a Frank-Wolfe style method [15] to the continuous relax-
ation. The result is Full-ActionChoice (Alg. 2), a gradient-based
algorithm that runs for 𝐿 iterations, simultaneously updating the
actions taken at each round. It begins with an arbitrary feasible
point and performs three steps per iteration: (i) computes the gra-
dient of the objective at the current point, (ii) optimizes the linear
approximation to the objective over the true (not relaxed) feasible
set, and (iii) steps toward it. After 𝐿 iterations, we greedily round
the solution, selecting the 𝑘 nodes that have highest values. Each
time we receive a new naturally cured set, we run Alg. 2 over all
remaining rounds and output the action for the current time.
We describe Alg. 2 in more detail. We initialize to an arbitrary
feasible point in Ψ, the convex hull of the binary valued R𝑎 (𝑡):
we choose R0𝑎 (𝑡) = 0 for 𝑡 = 𝑡0 ∼ 𝑇 in iteration 𝑙 = 0 (line 1).
In each iteration, we need to caluclate the gradient of 𝐹 w.r.t. the
action choice, which is the GradientOracle of line 4. We relax
Algorithm 2 Full-ActionChoice
Input: A, b¯(𝑡0), 𝛼 , 𝑐 , 𝑇 , 𝑡0, 𝑘
Output: 𝐶𝑎 (𝑡0)
1: R0𝑎 (𝑡) ← 0 ∀𝑡
2: for 𝑙 = 1...𝐿 do
3: for 𝑡 = 𝑡0 ...𝑇 do
4: ∆(𝑡) ← GradientOracle(R𝑙−1𝑎 )
5: R∗𝑎 (𝑡) ← ProjectFeasible(Δ, 𝑘)
6: R𝑙𝑎 (𝑡) ← (1 − 𝛾𝑙 )R𝑙−1𝑎 (𝑡) + 𝛾𝑙R∗𝑎 (𝑡)
7: end for
8: end for
9: 𝐶𝑎 (𝑡0) ← arg max𝑘 R𝐿𝑎 (𝑡0)
10: return 𝐶𝑎 (𝑡0)
the optimization to the continuous problem by allowing R𝑎 (𝑡)𝑣,𝑣 to
take real values between 0 and 1, which can be interpreted as the
probability of choosing node 𝑣 . By taking the derivative of 𝐹 , the
gradient w.r.t. action at each time 𝑡 is
𝜕𝐹
𝜕R𝑎 (𝑡 ) = −
𝑇∑
𝑡′=𝑡+1
𝑡+1∏
𝜏=𝑡′
M⊤𝑎 (𝜏)1x⊤ (𝑡0)
𝑡0∏
𝜏=𝑡−1
M⊤𝑎 (𝜏), (7)
The above gradient is a matrix Δ(𝑡), where the diagonal elements
Δ(𝑡)𝑣,𝑣 represent the gradient w.r.t. the choice of node 𝑣 to actively
screen at time 𝑡 .
We then minimize this linear approximation over the true fea-
sible set. Since the objective is linear and the only constraints are
individual variable bounds and the budget constraint, we can opti-
mize exactly by greedily selecting the 𝑘 nodes with largest Δ(𝑡)𝑣,𝑣
in line 5. We set the initial point R𝑙𝑎 (𝑡) of the next iteration in line 6,
in which 𝛾𝑙 = 2/(𝑙 + 2) is the step size of Frank-Wolfe algorithm.
Since Ψ is convex and R𝑙𝑎 (𝑡) is the convex combination of two fea-
sible points, it is guaranteed that it will remain in the convex hull
Ψ after the update. After 𝐿 iterations, we output our action in the
current round by greedily selecting 𝑘 nodes of the relaxed R𝐿𝑎 (𝑡0)
of the final iteration, as line 9 shows.
The Full-REMEDY algorithm considers future actions simul-
taneously and has time complexity of 𝑂 (𝑇 2 |𝑉 |𝜔 ), where the ex-
ponent 𝜔 arises from complexity of matrix multiplication (best
known 𝜔 is around 2.37). The algorithm used scales well to the
budget 𝑘 . However, calculating such solutions for a very large
network—which is often the case for active screening—can be time
consuming. To reduce time complexity, we further simplify the
upper-bound function by assuming that no actions are taken in
the future rounds and ignore their effect on the current decision
making in Fast-ActionChoice (Alg. 3). By ignoring future actions,
the action matrix𝑀𝑎 (𝑡) in Full-REMEDY is simplified to constant
𝑀 . The contribution of actively screening each node can be written
as the following vector form:
1
⊤∑𝑇−𝑡0−1
𝜏=0
M𝜏𝑑𝑖𝑎𝑔 (M𝑛x(𝑡0)), (8)
where M𝑛 = (I − R𝑛 (𝑡0))M′. Now, since M is the same for every
future round, M can be decomposed as QΛQ⊤ ahead of time, where
Q is a matrix comprised of the eigenvectors of M, and Λ a diagonal
matrix comprised of the eigenvalues along the diagonal. Such a
matrix can be approximated by calculating only the top𝑚 largest
eigenvalues and their eigenvectors using the Lanczos algorithm
[24] that has a complexity of 𝑂 ( |𝐸 |) (assuming the large network
Algorithm 3 Fast-ActionChoice
Input: A, b¯(𝑡0), 𝛼 , 𝑐 , 𝑇 , 𝑡0, 𝑘
Output: 𝐶𝑎 (𝑡0)
1: if 𝑡0 = 0 then
2: M ← 𝛼A + (1 − 𝑐)I
3: Q𝑚,Λ𝑚 ← Lanczos(M,𝑚)
4: end if
5: Scores← 1⊤Q𝑚 (∑𝑇−𝑡0−1𝜏=0 Λ𝜏𝑚)Q⊤𝑚𝑑𝑖𝑎𝑔(M𝑛x(𝑡0))
6: 𝐶𝑎 (𝑡) ← 𝑘 nodes with highest scores in vector Scores
is sparse), yielding the Fast-ActionChoice shown in Alg. 3. The
approximate M is given by Q𝑚Λ𝑚Q⊤𝑚 , where these matrices are
computed in line 3. In line 5, the well-known result (Q𝑚Λ𝑚Q⊤𝑚)𝜏 =
Q𝑚Λ𝜏𝑚Q⊤𝑚 is used to approximate M𝜏 . The time complexity of Fast-
REMEDY is 𝑂 ( |𝑉 |2) assuming constant𝑚.
5 EXPERIMENTS
We perform experiments comparing Fast- and Full-REMEDY to
baselines on a variety of real-world datasets. Table 1 lists the net-
works and their properties. Most of the networks were collected in
human contact settings. The networks are carefully selected to have
significant variation in size, degree, average shortest path length,
assortativity and epidemic threshold (spectral radius).
Setting. Unless explicitly stated otherwise, we assume the budget
𝑘 allows for screening and treatment of 20% of the total population
|𝑉 | per round. All results are averages over 30 runs.
In practice, active screening is performed only after conducting
initial surveys on the prevalence and incidence of the disease. To
simulate this, we run experiments in two stages.
Stage 1 (Survey Stage). This stage starts at 𝑡 = 0 with 25% of
individuals in 𝐼 , selected uniformly at random, and ends at 𝑡 = 10.
No active screening is done and the disease evolves naturally. The
initial belief b(0) for all nodes is assumed to be [0.5, 0.5]⊤ since
we have no prior information. Beliefs are updated according to the
belief update algorithm in the Disease model section. This belief
update requires knowledge of 𝛼 and c. There is a rich literature of
how to estimate the disease parameters (𝛼 and 𝑐) in this stage and
these methods have been tested on real-world scenarios [11, 23, 33].
Here, we assume that such parameters are known.
Such parameters can vary from disease to disease. For example,
the transmission rate of Pertussis can be as high as 0.47 for certain
age groups [18], and as low as 0.035 for Syphilis [33]. The cure rate
also depends on how resourceful the target regions are. We initially
assume (𝛼, 𝑐) = (0.1, 0.1) and then evaluate a range of values.
Stage 2 (ACTS Stage). Here, we consider various screening algo-
rithms. We perform active screening from 𝑡 = 11 to 𝑡 = 𝑇 = 20 to
represent 5 years of time (each round is 6 months [8]). Beliefs are
updated according to the belief update scheme presented in Disease
Model and Background section.
5.1 Metrics
We compare the outcomes of the following screening strategies
compared to no intervention (None). In None, the evolution of
the health states is based on disease dynamics only, with no active
screening for all𝑇 rounds. The improvement overNone is reported
as the number of fewer infections as compared to None. Thus, the
larger this number the better the performance of the algorithm.
(1a) Random: Randomly select nodes for active screening.
(1b) MaxDegree: Successively choose nodes with the largest
degree until the budget is reached.
(1c) Eigenvalue: Greedily choose nodes that reduce the largest
eigenvalue of A the most until the budget is reached.
(1d) MaxBelief: Choose nodes with the highest probability of
being in the 𝐼 state.
(1e) BeliefCutWidth: Amodified version of the CutWidthmethod
for a problem with known infection state [12, 36]. Since the
original method requires known infection state, we modi-
fied it by using a sample from the marginal belief state as a
substitute of the true state.
Unfortunately, the data sets from countries that have high infec-
tious disease burden, for which the algorithms may be applied on
the ground in the future, have restrictive terms of use. For privacy
and security reasons, they cannot be shared externally. Instead,
we present the result of testing these algorithms on the following
realistic contact networks collected from diverse sources.
(2a) Hospital [41]: A dense contact network collected in a uni-
versity hospital to study the path of disease spread.
(2b) India [4]: A human contact network collected from a rural
village in India where active screening with limited budget
may take place.
(2c) Face-to-face [21]: A network describing face-to-face con-
tact in which influenza might spread through the close con-
tact of individuals.
(2d) Flu [35]: A network of close proximity interactions in an
American high school.
(2e) Irvine [28]: A friendship network collected from students in
UC Irvine, used to study rumor modeled as epidemic spread.
(2f) Escort [32]: A sexual contact network between escorts and
sex buyers in which STDs may be spread collected over six
years.
(2g) Epinion [25]: A trust network of a general consumer review
site. This dataset is adopted mainly to show the scalability
of the algorithms.
The results are shown in Table 1. We begin with initial observa-
tions and provide a more detailed analysis in the following section.
In most cases, although the baselines behave differently for each
data set, both versions of REMEDYmake substantial improvements
over them, and, as expected, Full-REMEDY exhibits better per-
formance than Fast-REMEDY. In Irvine, the largest network for
which all the algorithms are able to complete running within a
24-hour period, Fast-REMEDY and Full-REMEDY outperformed
MaxDegree, the next best competitor, by 16.29% and 36.23% respec-
tively. Fast-REMEDY also outperformed its next best competitor
(MaxDegree) on Epinion, the largest network, by 37.44%. We fur-
ther examined the performance of REMEDY for a range of 𝛼 and 𝑐
values (see Fig. 4). FAST- and FULL-REMEDY continue to perform
better than their closest competitors.
Specifically, Fig. 3 shows the average number of infected nodes
in each round on the India network. The values shown in Table 1
are the accumulation of the difference between None and each al-
gorithm. Full-REMEDY steadily outperforms the other algorithms
Network |𝑉 | 1𝜆∗𝐴 𝑑 𝜌𝐿 𝜌𝐷
Number of reduced infections
Random Max-Degree Eigenvalue Max-Belief BeliefCutWidth Fast-REMEDY Full-REMEDY
Hospital [41] 75 0.027 15.19 1.60 -0.18 144 150 151 150 147 156 160
India [4] 202 0.095 3.43 3.11 0.02 605 470 420 636 754 890 901
Face-to-face [21] 410 0.042 6.74 3.63 0.23 809 843 745 1057 1100 1297 1409
Flu [35] 788 0.003 150.12 1.62 0.05 1336 1421 1431 1438 1396 1443 1446
Irvine [28] 1899 0.021 7.29 3.06 -0.18 4630 5741 3692 4957 5623 6676 7821
Escorts [32] 16730 0.032 2.33 4.20 -0.03 27400 30167 TLE 29493 TLE 46549 TLE
Epinion [25] 75879 0.004 2.67 4.40 -0.04 187369 228174 TLE 207565 TLE 285280 TLE
Table 1: Improvement over None in terms of the number of reduced infections (the larger the better).All computations are carried
out with 𝛼 = 0.1, 𝑐 = 0.1. Here, TLE signifies that the 24 hour limit was exceeded.
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Figure 3: The average number of infected nodes (𝑦-axis) vs.
time (𝑥-axis) of the ACTS stage in the India network.
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Figure 4: Improvement over None (y-axis) under different
parameter settings for India network.
in each round and keeps decreasing the infected node number and
Fast-REMEDY follows slightly behind it. The other algorithms,
however, reach steady state and stop decreasing earlier.
Fig. 5 gives the running time of all the algorithms in different
networks, sorted by size. Fast-REMEDY is about two orders of
magnitude faster compared to Full-REMEDY, and takes about two
hours on the largest network. All the algorithms that select a fixed
set of nodes (Eigenvalue and MaxDegree) in every round are
timed for the first round only for fairness of comparison. On Escort
and Epinion, Eigenvalue, BeliefMaxCut and Full-REMEDY ex-
ceed 24 hours of computation time. It appears that only algorithms
with complexity of 𝑂 ( |𝑉 |2) or less terminate within the time limit.
5.2 Policy Analysis: Cure, Prevent, and Miss
To analyze the performance differences between algorithms, we
introduce metrics that decompose the effect of active screening. As
Figure 6 shows, screening a node has one of the following three
effects:
• Cure: screening a node that is currently in the 𝐼 state causes
that node to transition to the 𝑆 state.
• Prevent: screening a node in the 𝑆 state prevents that node
from entering the 𝐼 state if it would have otherwise.
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Figure 5: Computation time (𝑦-axis, in seconds) in different
contact networks in logarithmic scale.
• Miss: screening a node in the 𝑆 state has no effect if that
node would not have transitioned to the 𝐼 state.
We analyze the performance of the algorithms by measuring how
many of their active screening actions result in each effect. Figure 7
shows the frequency of each effect for each algorithm, averaged
over the rounds in the ACTS stage.
Effect III : Miss
Round end Next round start
Effect I : Cure Effect II : Prevent
Not Actively Screened
Actively Screened
Round end Next round start
Not Actively Screened
Actively Screened
Round end Next round start
Not Actively Screened
Actively Screened
Susceptible Infected
Figure 6: Three possible effects of active screening.
Active screening actions that cure infected nodes or prevent
susceptible nodes from becoming infected will generally decrease
the amount of infection in the network, whereas a miss has no
effect. Therefore, we expect that algorithms with higher combined
cure and prevention rates should have higher performance. This is
indeed the case as the height of combined cure and prevention in
Figure 7 is strongly correlated to the performance in Table 1 with
only a few exceptions. The success of Fast- and Full-REMEDY can
be explained primarily along these lines. Due to space constraints,
a more detail analysis of the performance variation of each algo-
rithm on each network based on their properties and three active
screening effects is provided in the supplemental material.
6 DEPLOYMENT CONSIDERATIONS
In this section, we consider the effect of practical constraints on
deployment of REMEDY in real-world active screening situations.
Our ultimate aim is to be able to use the algorithms in settings such
as active screening for tuberculosis in India.
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Figure 7: Frequency of each active screening effect, averaged over the ACTS stage. (R.: Random; M.D.:MaxDegree; E.:Eigenvalue;
M.B.:MaxBelief; B.M.C.: BeliefMaxCut; Fasr-R:Fast-REMEDY; Full-R.:Full-REMEDY)
Active screening implementations usually choose to screenwhole
districts where disease infections are severe. Recent experimental
attempts that involved screening every first degree contact of re-
ported patients (these are designated as Naturally Cured in this
paper)[20]. To address the challenge of deploying this work as a
next step in active screening implementations, it is essential to take
into account realistic barriers such as limited budget or missing
information about the contact structure.
6.1 Impact of Budget
Determining the improvement an intervention can achieve with
various budgets is critical when informing health policy. We there-
fore study the improvement possible over different budget values
for two realistically modeled diseases: Influenza and Syphilis.
Influenza. For Influenza, we use parameters estimated by pre-
vious literature through a continuous survey administered in a
student residence hall community [11]. The transition rate is es-
timated to be 𝛼 = 0.024 and the self-cure rate is estimated to be
𝑐 = 0.3. We test the algorithms on the Face-to-face network, since
this network is used to study the dynamics of SIS-type epidemic
spread in its original paper [21].
Fig. 8 (a) shows that both Fast-REMEDY and Full-REMEDY out-
perform other baselines under realistic settings. The difference
grows larger as the budget increases. According to Prakash et
al. [29], such a network requires at least 𝑘/|𝑉 | ≥ 𝛼𝜆𝐴 = 57%
for random screening to fully eradicate the disease. However, the
epidemic dies out at the end of the 20th round (in all runs) when
Full-REMEDY is deployed with a budget of only 𝑘/|𝑉 | = 15%.
Syphilis. We use the syphilis parameters derived by Saad-Roy
et al. [33]. The natural cure rate is estimated to be 𝑐 = 0.01 and
transmission rate 𝛼 = 0.035. The network is the Escort network
with 16730 nodes, an STD contact network. Because the network is
large, we show only the algorithms that do not exceed running time
due to time complexity, which are Random, MaxDegree, MaxBelief
and Fast-REMEDY. Fig. 8 (b) shows that Fast-REMEDY achieves
significantly better results than all other baselines. On average, it
saves 1140, 2900, and 4600 people from becoming infected every
six months for 5%, 10% and 15% budgets, respectively.
6.2 Impact of Structure Uncertainty
In realistic settings, it is quite possible that the contact network is
not known precisely. To simulate this, we randomly remove edges
from the graph and then provide the graph with missing edges as
input to the algorithms. All the algorithms make decisions based
on this graph with missing edges without knowing such fact while
the disease spread happens along the true network with all edges.
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Figure 8: Improvement over None (y-axis) with specific dis-
ease parameters under different budget constraints (corre-
sponding to 5%, 10%, 15% of total population).
0
200
400
600
800
1000
1200
Random MaxDegree Eigenvalue MaxBelief BeliefMaxCut Fast-REMEDY Full-REMEDY
0.00% 20.00% 40.00% 60.00% 80.00%
Figure 9: The improvement over None for different percent-
age of edge information lost in the India network.
Both version of REMEDY still significantly outperform other
baselines even when the percentage of edges randomly removed is
as high as 80% (Fig. 9). In other words, it is able to outperform the
other implementations with only 20% of the contacts are known.
7 CONCLUSION
This paper presents the REMEDY agent for a novel active screen-
ing multiagent problem (ACTS) that takes into account real world
constraints such as uncertain health states and limited intervention
resources. No previous work has addressed the challenge of such
uncertainty raised from the emerging application active screening
of recurrent diseases. Active screening provides a powerful yet ex-
pensive means to control disease spread in the public health domain
that passive screening cannot achieve due to its latency of cure. The
agent is developed to assist our collaborator in India to decide who
and when health workers should invest their limited resources and
improve the current practice approach. We introduced two variant
of algorithms the agent used, Full-REMEDY and Fast-REMEDY
and examined them on various real human contact networks and
realistic disease parameters to show their superior performance
over any past approach.
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